References
1. Knight R. The relationship between new variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Vox Sang 1999; 76: 203–208.
2. Lorains JW, Henry C, Agbamu DA, et al. Variant Creutzfeldt-Jakob disease in an elderly patient. Lancet 2001; 357: 1339–1340.
3. Prusiner SB. Shattuck Lecture: Neurodegenerative diseases and prions. N Engl J Med 2001; 344: 1516–1526.
4. Sivakumar R, Barrett JA, Ironside JW, et al. Creutzfeldt-Jakob disease presenting as recurrent falls in an older person. Age Ageing 2001; 30: 356–357(letter).
5. Jiang TT, Moses H, Gordon H, et al. Sporadic Creutzfeldt-Jakob disease presenting as major depression. South Med J 1999; 92: 807–808.
6. Pachalska M, Kurzbauer H, MacQueen BD, et al. Neuropsychological features of rapidly progressive dementia in a patient with an atypical presentation of Creutzfeldt-Jakob disease. Med Sci Monit 2001; 7: 1307–1315.
7. DeArmond SJ, Prusiner SB. Etiology and pathogenesis of prion diseases. Am J Pathol 1995; 146: 785–811.
8. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177–188.
9. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513–529.
10. de Silva R, Findlay C, Awad I, et al. Creutzfeldt-Jakob disease in the elderly. Postgrad Med J 1997; 73: 557–559.
11. Gibbons RV, Holman RC, Belay ED, et al. Creutzfeldt-Jakob disease in the United States: 1979–1998. JAMA 2000; 284: 2322–2323(letter).
12. Schroter A, Zerr I, Henkel K, et al. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000; 57: 1751–1757.
13. Poser S, Mollenhauer B, Kraubeta A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122: 2345–2351.
14. Whittle IR, Will RG, Ironside JW. Brain biopsy and patients with atypical presentations of sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1997; 63: 547–548(letter).
15. Shapiro MF, Hayward RA, Guillemot D, et al. Residents’ experiences in, and attitudes toward, the care of persons with AIDS in Canada, France, and the United States. JAMA 1992; 268: 510–515.
16. Steelman VM. Creutzfeldt-Jakob disease: Recommendations for infection control. Am J Infect Control 1994; 22: 312–318.
17. Ironside JW, Bell JE. The “high-risk” neuropathological autopsy in AIDS and Creutzfeldt-Jakob disease: Principles and practice. Neuropathol Appl Neurobiol 1996; 22: 388–393.
18. Budka H, Aguzzi A, Brown P, et al. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 319–322.
19. World Health Organization.
WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies: Report of a WHO Consultation, Geneva Switzerland, 23–26 March 1999(WHO/CDS/CSR/APH/2000.3). Geneva, World Health Organization, 1999. Available at:
http:/who.int/emc-documents/tsc/docs/whocdscsraph2003.pdf. Accessed June 17, 2003.